MolecuLight Inc. a privately-owned medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology in multiple clinical markets. MolecuLight’s suite of commercially released devices, including the MolecuLight i:X® and DX™ fluorescence imaging systems and their accessories, provide point-of-care handheld imaging devices for the global wound care market for the real-time detection of wounds containing elevated bacterial burden > 10^4 CFU/g (when used with clinical signs and symptoms) and for digital wound measurement #moleculight
Looking for a particular MolecuLight employee's phone or email?
The MolecuLight annual revenue was $8 million in 2026.
Anil Amlani is the CEO at MolecuLight Inc of MolecuLight.
61 people are employed at MolecuLight.
MolecuLight is based in Toronto, Ontario.
The NAICS codes for MolecuLight are [339, 33].
The SIC codes for MolecuLight are [38, 384].